SCHEMBL21030892

SCHEMBL21030892

Cn1c2ccccc2c2ccc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.54
▸ RXRB P28702 1/20 0.54
▸ KDM4E B2RXH2 5/20 0.47
▸ L3MBTL1 Q9Y468 4/20 0.47
▸ ATM Q13315 1/20 0.47
▸ GPR3 P46089 1/20 0.46
▸ HPGD P15428 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ KIF11 P52732 1/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ TSPO P30536 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18180845 0.97 RXRA (0.54) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL18595613 0.97 RXRA (0.53) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL16791297 0.96 RXRA (0.53) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL26528387 0.96 KDM4E (0.52) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL21031226 0.96 KDM4E (0.52) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL16791292 0.94 RXRA (0.54) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL17038391 0.94 RXRA (0.51) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL17038395 0.94 RXRA (0.51) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL17038398 0.94 RXRA (0.51) RXRARXRBKDM4EL3MBTL1ATM
SCHEMBL15747044 0.94 KDM4E (0.55) RXRARXRBKDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 RXRA 3694/4885RXRB 2971/4885KDM4E 962/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 RXRA 3694/4885RXRB 2971/4885KDM4E 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback